Ashland Global (ASH) revenue breakdown
By segment, Life Sciences is the largest at 34% of fiscal 2025 revenue, growing -2% a year over 7 years.
By region, International is the largest at 75% of fiscal 2025 revenue, growing -3% a year over 9 years.
Revenue by segment
Fiscal years, as Ashland Global reports them in its 10-K filings; fiscal 2025 total $1.9B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Life Sciences | — | — | $731M | $732M | $708M | $737M | $815M | $869M | $810M | $641M | 34% |
| Personal Care | — | — | $702M | $651M | $615M | $592M | $678M | $598M | $634M | $577M | 31% |
| Specialty Additives | — | — | $686M | $654M | $589M | $655M | $719M | $600M | $572M | $511M | 27% |
| Intermediates | $261M | $93M | $155M | $160M | $129M | $178M | $256M | $185M | $144M | $137M | 7% |
| Specialty Ingredients | $2.1B | $2.2B | — | — | — | — | — | — | — | — | — |
| Composites | $669M | — | — | — | — | — | — | — | — | — | — |
| Performance Adhesives | — | — | $351M | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Ashland Global reports them in its 10-K filings; fiscal 2025 total $1.8B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| International | $1.9B | $1.4B | $1.6B | $1.5B | $1.4B | $1.5B | $1.7B | $1.6B | $1.5B | $1.4B | 75% |
| United States Pension Plans of US Entity, Defined Benefit | $1.2B | $880M | $997M | $674M | $623M | $637M | $731M | $634M | $624M | $464M | 25% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ASH.
Open ASH in InvestinglyQuestions
Where does Ashland Global make its money?
In fiscal 2025, by segment: Life Sciences $641M, Personal Care $577M, Specialty Additives $511M, Intermediates $137M.
From Ashland Global's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.